Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atropine 0.05% for myopia progression control in children
PACTR202505621383018Not yet recruiting
- Sponsor
- Hawassa University
- Start
- Sep 2025
- Modality
- Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Trial of atropine and artificial tears in myopia (2 arms), sponsored by Hawassa University. Primary endpoint: mean spherical equivalent myopia progression. Planned start Sep 2025; status: not yet recruiting.
02
Drugs
atropineartificial tears
03
Conditions
myopia
Beyond the preview
Go deeper on PACTR202505621383018.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202505621383018.